SEARCH

SEARCH BY CITATION

References

  • 1
    Bhagwat, S.S. & William, M. (1997) P2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors. European Journal of Medicinal Chemistry, 32, 183 193.
  • 2
    Boyer, J.L., Romero-Avila, T., Schachter, J.B., Harden, T.K. (1996) Identification of competitive antagonists of the P2Y1 receptor. Molecular Pharmacology, 50, 1323 1329.
  • 3
    Cazenave, J.P., Hemmendinger, S., Beretz, A., Sutter-Bay, A., Launay, J. (1983) L'agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Annales de Biologie Clinique, 41, 167 179.
  • 4
    Clifford, E.E., Parker, K., Humphreys, B.D., Kertesy, S.B., Dubyak, G.R. (1998) The P2X1 receptor, an adenosine triphosphate-gated cation channel is expressed in human platelets but not in human blood leukocytes. Blood, 91, 3172 3181.
  • 5
    Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J.M. (1998) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. Journal of Biological Chemistry, 272, 31969 31973.
  • 6
    Daniel, J.L., Dangelmaier, C.A., Jin, J., Ashby, B., Smith, J.B., Kunapuli, S.P. (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. Journal of Biological Chemistry, 273, 2024 2029.
  • 7
    Daniel, J.L., Dangelmaier, C.A., Selak, M., Smith, J.B. (1986) ADP stimulates IP3 formation in human platelets. FEBS Letters, 206, 299 303.
  • 8
    Defreyn, G., Gachet, C., Savi, P., Driot, F., Cazenave, J.P., Maffrand, J.P. (1991) Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits . Thrombosis and Haemostasis, 65, 186 190.
  • 9
    Gaardner, A., Jonsen, J., Laland, S., Hellem, A., Owen, P.A. (1961) Adenosine diphosphate in red cells as a factor in adhesiveness of human blood platelets. Nature, 192, 531 532.
  • 10
    Gachet, C., Cattaneo, M., Ohlmann, P., Hechler, B., Lecchi, A., Chevalier, J., Cassel, D., Mannucci, P.M., Cazenave, J.P. (1995) Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. British Journal of Haematology, 91, 434 444.
  • 11
    Gachet, C., Cazenave, J.P., Ohlmann, P., Bouloux, C., Defreyn, G., Driot, F., Maffrand, J.P. (1990) The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Biochemical Pharmacology, 40, 2683 2687.
  • 12
    Gachet, C., Cazenave, J.P., Ohlmann, P., Hilf, G., Wieland, T., Jakobs, K.H. (1992) ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes. European Journal of Biochemistry, 207, 259 263.
  • 13
    Gachet, C., Hechler, B., Leon, C., Vial, C., Leray, C., Ohlmann, P., Cazenave, J.P. (1997) Activation of ADP receptors and platelet function. Thrombosis and Haemostasis, 78, 271 275.
  • 14
    Haslam, R.J. (1973) Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. Series Haematological 6, 333 350.
  • 15
    Hechler, B., Léon, C., Vial, C., Vigne, P., Frelin, C., Cazenave, J.P., Gachet, C. (1998 a) The P2Y1 receptor is necessary for ADP-induced platelet aggregation. Blood, 92, 152 159.
  • 16
    Hechler, B., Vigne, P., Léon, C., Breittmayer, J.P., Gachet, C., Frelin, C. (1998 b) ATP derivatives are antagonists of the P2Y1 receptor: similarities with the platelet ADP receptor. Molecular Pharmacology, 53, 727 733.
  • 17
    Heermskerk, J.W.M. & Sage, S.O. (1994) Calcium signalling in platelets and other cells. Platelets, 5, 295 316.
  • 18
    Hellem, A.J. (1960) The adhesiveness of human blood platelets in vitro. Scandinavian Journal of Clinical and Laboratory Investigation, 12, 1 117.
  • 19
    Herbert, J.M., Frehel, D., Vallee, E., Kieffer, G., Gouy, D., Berger, Y., Necciari, J., Defreyn, G., Maffrand, J.P. (1993) Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovascular Drugs Review, 11, 180 198.
  • 20
    Hourani, S.M.O. & Hall, D.A. (1996) P2T purinoceptors: ADP receptors on platelets. P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 53 70. Ciba Foundation Symposium 198. Wiley, Chichester.
  • 21
    Humphries, R.G., Robertson, M.J., Leff, P. (1995 a) A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends in Pharmacological Sciences, 16, 179 181.
  • 22
    Humphries, R.G., Tomlinson, W., Clegg, J.A., Ingall, A.H., Kindon, N.D., Leff, P. (1995 b) Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. British Journal of Pharmacology, 115, 1110 1116.
  • 23
    Humphries, R.G., Tomlinson, W., Ingall, A.H., Cage, P.A., Leff, P. (1994) FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors . British Journal of Pharmacology, 113, 1057 1063.
  • 24
    Jin, J., Daniel, J.L., Kunapuli, S.P. (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. Journal of Biological Chemistry, 273, 2030 2034.
  • 25
    Khym, J.X. (1975) An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clinical Chemistry, 21, 1245 1252.
  • 26
    Lanza, F., Beretz, A., Stierle, A., Hanau, D., Kubina, M., Cazenave, J.P. (1988) Epinephrine potentiates human platelet activation but is not an aggregating agent. American Journal of Physiology, 255, 1276 1288.
  • 27
    Léon, C., Hechler, B., Vial, C., Leray, C., Cazenave, J.P., Gachet, C. (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Letters, 403, 26 30.
  • 28
    Macfarlane, D.E. (1987) Agonists and receptors: adenosine diphosphate. Responses and Metabolism (ed. by H. Holmsen), pp. 19 36.
  • 29
    MacKenzie, A., Mahaut-Smith, M.P., Sage, S.O. (1996) Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. Journal of Biological Chemistry, 271, 2879 2881.
  • 30
    Maffrand, J.P., Bernat, A., Delebassee, D., Defreyn, G., Cazenave, J.P., Gordon, J.L. (1988) ADP plays a key role in thrombogenesis in rats. Thrombosis and Haemostasis, 59, 225 230.
  • 31
    Mills, D.C. (1996) ADP receptors on platelets. Thrombosis and Haemostasis, 76, 835 856.
  • 32
    Mills, D.C., Puri, R.N., Hu, C.J., Minniti, C., Grana, G., Freedman, M., Colman, R.F., Colman, R.W. (1992) Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Atherosclerosis and Thrombosis, 12, 430 436.
  • 33
    Munson, P.J. & Rodbard, D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry, 107, 220 239.
  • 34
    North, A. & Barnard, E.A. (1997) Nucleotide receptors. Current Opinion in Neurobiology, 7, 346 357.
  • 35
    Offermanns, S., Toombs, C.F., Hu, Y.H., Simon, M.I. (1997) Defective platelet activation in Gαq-deficient mice. Nature, 389, 183 186.
  • 36
    Raha, S., Jones, G.D., Gear, A.R.L. (1993) Sub-second oscillations of inositol 1,4,5-triphosphate and inositol 1,3,4,5-tetrabisphosphate during platelet activation by ADP and thrombin: lack of correlation with calcium kinetics. Biochemical Journal, 292, 643 646.
  • 37
    Savi, P., Beauverger, P., Labouret, C., Delfaud, M., Salel, V., Kaghad, M., Herbert, J.M. (1998) Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Letters, 422, 291 295.
  • 38
    Savi, P., Laplace, M.C., Maffrand, J.P., Herbert, J.M. (1994) Binding of [3H]-2-methylthio-ADP to rat platelets: effects of clopidogrel and ticlopidine . Journal of Phamacology and Experimental Therapeutics, 269, 772 777.
  • 39
    Scase, T.J., Heath, M.F., Allen, J.M., Sage, S.O., Evans, R.J. (1998) Identification of a P2X1 purinoceptor expressed on human platelets. Biochemical and Biophysical Research Communications, 2423, 525 528.
  • 40
    Schrör, K. (1993) The basic pharmacology of ticlopidine and clopidogrel. Platelets, 4, 252 261.
  • 41
    Sun, B., Li, J., Okahara, K., Kambayashi, J. (1998) P2X1 purinoceptor in human platelets. Journal of Biological Chemistry, 273, 11544 11547.
  • 42
    Vial, C., Hechler, B., Léon, C., Cazenave, J.P., Gachet, C. (1997) Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thrombosis and Haemostasis, 78, 1500 1504.
  • 43
    Vickers, J.D., Kinlough-Rathbone, R.L., Packham, M.A., Mustard, J.F. (1990) Inositol phospholipid metabolism in human platelets stimulated by ADP. European Journal of Biochemistry, 193, 521 528.
  • 44
    Williams, M. (1996) Challenges in developing P2 purinoceptor-based therapeutics. P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 309 321. Ciba Foundation Symposium 198. Wiley, Chichester.